Viatris Agrees to Settle EpiPen Antitrust Disputes for $264 Million
Viatris, the drug maker formerly known as Mylan, announced Monday that it agreed to pay $264 million to settle a ...
Viatris, the drug maker formerly known as Mylan, announced Monday that it agreed to pay $264 million to settle a ...
We bring you the Breaking News,Latest Stories,World News, Business News, Political News, Technology News, Science News, Entertainment News, Sports News, Opinion News and much more from all over the world